top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Neuroimaging and Psychosocial Addiction Treatment [[electronic resource] ] : An Integrative Guide for Researchers and Clinicians / / edited by Sarah W. Feldstein Ewing, Katie Witkiewitz, Francesca M. Filbey
Neuroimaging and Psychosocial Addiction Treatment [[electronic resource] ] : An Integrative Guide for Researchers and Clinicians / / edited by Sarah W. Feldstein Ewing, Katie Witkiewitz, Francesca M. Filbey
Edizione [1st ed. 2015.]
Pubbl/distr/stampa London : , : Palgrave Macmillan UK : , : Imprint : Palgrave Macmillan, , 2015
Descrizione fisica 1 online resource (293 p.)
Disciplina 362.29
Soggetto topico Clinical psychology
Neurosciences
Social policy
Biological psychology
Public health
Psychology, Pathological
Clinical Psychology
Social Policy
Biological Psychology
Public Health
Psychopathology
ISBN 1-349-56759-0
Classificazione MED057000MED112000PSY007000PSY024000PSY038000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Title""; ""Copyright""; ""Contents""; ""List of Tables""; ""List of Figures""; ""Acknowledgments""; ""Preface""; ""References""; ""About the Editors""; ""List of Contributors""; ""Section I: Introduction""; ""1 Translational Approaches to Addiction Treatment""; ""I.?Background""; ""II.?Functional Magnetic Resonance Imaging (fMRI) and Behavioral Treatments""; ""A.?Cognitive Behavioral Therapy and fMRI""; ""B.?Motivational Interviewing and fMRI""; ""C.?Contingency Management and fMRI""; ""D.?f?MRI summary""; ""III.?Structural MRI and Behavioral Treatment Responses""
""A.?Gray matter: Findings from morphometric and cortical thickness studies""""B.?White matter: Findings from diffusion tensor imaging studies""; ""C.?Structural summary""; ""IV.?Ligand-Based Imaging: Assessing Endogenous Neurochemistry in Relation to Treatment Responses""; ""V.?Genetic Influences on Behavioral Treatment Response""; ""VI.?Emerging Therapies: Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation""; ""VII.?Summary, Clinical Implications, and Future Directions""; ""VIII.?Conclusions""; ""References""; ""2 Fundamentals of Addiction Neuroscience""
""I.?Neuroscience Approaches Toward the Understanding of Addiction""""A.?Non-human addiction research""; ""B.?Human addiction research""; ""II.?Behavior-Brain Models of Addiction""; ""A.?The opponent process theory""; ""B.?The incentive salience theory""; ""C.?The impaired response inhibition and salience attribution (I-RISA) model""; ""D.?The allostatic model""; ""E.?The cue-elicited craving model""; ""F.?The anhedonia hypothesis""; ""III.?Neurotransmitters and Addiction""; ""IV.?Conclusions""; ""References""; ""Section II: Translational Approaches with Adults""
""3 Using Clinical Neuroscience to Understand Addiction Treatment""""I.?Background""; ""II.?Psychosocial Treatment Effects on Neuroimaging Paradigms""; ""B.?Treatment effects on the neural substrates of cue reactivity""; ""III.?Prediction of Relapse from Neuroimaging Paradigms""; ""A.?Overview of extant studies""; ""B.?Prediction of relapse from cue-elicited activation""; ""C.?Prediction of relapse from other neuroimaging paradigms""; ""IV.?Conclusions and Future Directions""; ""References""; ""4 Neuropsychopharmacology in Addiction Treatment""; ""I.?Introduction""
""II.?fMRI and Treatment of Alcohol Dependence""""III.?fMRI and Treatment of Nicotine Dependence""; ""IV.?fMRI and Treatment of Stimulant Dependence""; ""V.?fMRI and Treatment of Opiate Dependence""; ""VI.?Conclusions""; ""References""; ""5 The Promise of Repetitive Transcranial Magnetic Stimulation to Treat Addiction""; ""I.?Background""; ""A.?What is repetitive transcranial magnetic stimulation (rTMS)?""; ""B.?The effects of rTMS in substance use disorders""; ""1.?Tobacco dependence""; ""2.?Alcohol dependence""; ""3.?Cocaine dependence""; ""4.?Methamphetamine dependence""
""C.?Concluding remarks""
Record Nr. UNINA-9910796569803321
London : , : Palgrave Macmillan UK : , : Imprint : Palgrave Macmillan, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroimaging and Psychosocial Addiction Treatment : An Integrative Guide for Researchers and Clinicians / / edited by Sarah W. Feldstein Ewing, Katie Witkiewitz, Francesca M. Filbey
Neuroimaging and Psychosocial Addiction Treatment : An Integrative Guide for Researchers and Clinicians / / edited by Sarah W. Feldstein Ewing, Katie Witkiewitz, Francesca M. Filbey
Edizione [1st ed. 2015.]
Pubbl/distr/stampa London : , : Palgrave Macmillan UK : , : Imprint : Palgrave Macmillan, , 2015
Descrizione fisica 1 online resource (293 p.)
Disciplina 362.29
Soggetto topico Clinical psychology
Neurosciences
Social policy
Biological psychology
Public health
Psychology, Pathological
Clinical Psychology
Social Policy
Biological Psychology
Public Health
Psychopathology
ISBN 1-349-56759-0
Classificazione MED057000MED112000PSY007000PSY024000PSY038000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Title""; ""Copyright""; ""Contents""; ""List of Tables""; ""List of Figures""; ""Acknowledgments""; ""Preface""; ""References""; ""About the Editors""; ""List of Contributors""; ""Section I: Introduction""; ""1 Translational Approaches to Addiction Treatment""; ""I.?Background""; ""II.?Functional Magnetic Resonance Imaging (fMRI) and Behavioral Treatments""; ""A.?Cognitive Behavioral Therapy and fMRI""; ""B.?Motivational Interviewing and fMRI""; ""C.?Contingency Management and fMRI""; ""D.?f?MRI summary""; ""III.?Structural MRI and Behavioral Treatment Responses""
""A.?Gray matter: Findings from morphometric and cortical thickness studies""""B.?White matter: Findings from diffusion tensor imaging studies""; ""C.?Structural summary""; ""IV.?Ligand-Based Imaging: Assessing Endogenous Neurochemistry in Relation to Treatment Responses""; ""V.?Genetic Influences on Behavioral Treatment Response""; ""VI.?Emerging Therapies: Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation""; ""VII.?Summary, Clinical Implications, and Future Directions""; ""VIII.?Conclusions""; ""References""; ""2 Fundamentals of Addiction Neuroscience""
""I.?Neuroscience Approaches Toward the Understanding of Addiction""""A.?Non-human addiction research""; ""B.?Human addiction research""; ""II.?Behavior-Brain Models of Addiction""; ""A.?The opponent process theory""; ""B.?The incentive salience theory""; ""C.?The impaired response inhibition and salience attribution (I-RISA) model""; ""D.?The allostatic model""; ""E.?The cue-elicited craving model""; ""F.?The anhedonia hypothesis""; ""III.?Neurotransmitters and Addiction""; ""IV.?Conclusions""; ""References""; ""Section II: Translational Approaches with Adults""
""3 Using Clinical Neuroscience to Understand Addiction Treatment""""I.?Background""; ""II.?Psychosocial Treatment Effects on Neuroimaging Paradigms""; ""B.?Treatment effects on the neural substrates of cue reactivity""; ""III.?Prediction of Relapse from Neuroimaging Paradigms""; ""A.?Overview of extant studies""; ""B.?Prediction of relapse from cue-elicited activation""; ""C.?Prediction of relapse from other neuroimaging paradigms""; ""IV.?Conclusions and Future Directions""; ""References""; ""4 Neuropsychopharmacology in Addiction Treatment""; ""I.?Introduction""
""II.?fMRI and Treatment of Alcohol Dependence""""III.?fMRI and Treatment of Nicotine Dependence""; ""IV.?fMRI and Treatment of Stimulant Dependence""; ""V.?fMRI and Treatment of Opiate Dependence""; ""VI.?Conclusions""; ""References""; ""5 The Promise of Repetitive Transcranial Magnetic Stimulation to Treat Addiction""; ""I.?Background""; ""A.?What is repetitive transcranial magnetic stimulation (rTMS)?""; ""B.?The effects of rTMS in substance use disorders""; ""1.?Tobacco dependence""; ""2.?Alcohol dependence""; ""3.?Cocaine dependence""; ""4.?Methamphetamine dependence""
""C.?Concluding remarks""
Record Nr. UNINA-9910816576203321
London : , : Palgrave Macmillan UK : , : Imprint : Palgrave Macmillan, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Therapist's guide to evidence-based relapse prevention [[electronic resource] /] / edited by Katie A. Witkiewitz, G. Alan Marlatt
Therapist's guide to evidence-based relapse prevention [[electronic resource] /] / edited by Katie A. Witkiewitz, G. Alan Marlatt
Pubbl/distr/stampa Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Descrizione fisica 1 online resource (394 p.)
Disciplina 616.891
616.8914
Altri autori (Persone) WitkiewitzKatie
MarlattG. Alan
Collana Practical resources for the mental health professional
Soggetto topico Mental illness - Relapse - Prevention
Substance abuse - Relapse - Prevention
Mental illness - Treatment
Substance abuse - Treatment
Soggetto genere / forma Electronic books.
ISBN 1-280-96243-7
9786610962433
0-08-047104-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; Therapist's Guide to Evidence-Based Relapse Prevention; Copyright page; Table of contents; Contributors; Preface; SECTION I: Introduction andOverview; Chapter 1: Overview of Relapse Prevention; COGNITIVE-BEHAVIORAL MODEL OF RELAPSE; RELAPSE PREVENTION INTERVENTIONS; SUMMARY AND CONCLUSIONS; REFERENCES; Chapter 2: High-Risk Situations: Relapse as a Dynamic Process; COGNITIVE BEHAVIORAL MODEL OF RELAPSE, REVISED; TONIC PROCESSES; PHASIC PROCESSES; DYNAMICAL SYSTEMS PROCESSES; EMPIRICAL BASIS FOR DYNAMIC MODEL; CLINICAL CASE ILLUSTRATION; SUMMARY OF CLINICAL IMPLICATIONS
DYNAMIC RELAPSE MODEL AND NONSUBSTANCE USE BEHAVIORREFERENCES; SECTION II: Application of Relapse Prevention to Specific Problem Areas; Chapter 3: Relapse Prevention: Clinical Strategies for Substance Use Disorders; INTRODUCTION; OVERVIEW OF LAPSE, RELAPSE, AND RECOVERY; TREATMENT OUTCOMES AND RELAPSE RATES; EFFECTIVENESS AND EFFICACY OF RP; RELAPSE REPLICATION AND EXTENSION PROJECT; MODELS OF RELAPSE PREVENTION; RELAPSE-RELATED DOMAINS OF ASSESSMENT; RP INTERVENTIONS TO MINIMIZE LAPSE AND RELAPSE RISK; CLINICAL STRATEGIES TO REDUCE RELAPSE RISK
RP IN THE CONTEXT OF SUDs WITH COMORBID PSYCHIATRIC DISORDERSFUTURE RESEARCH DIRECTIONS; CLINICAL CASE ILLUSTRATIONS; CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; INTERNET RESOURCES; Chapter 4: Mindfulness-based Cognitive Therapy as a Relapse Prevention Approach to Depression; INTRODUCTION TO MINDFULNESS-BASED COGNITIVE THERAPY (MBCT); DEFINITION OF MINDFULNESS; EMPIRICAL SUPPORT FOR MBCT IN PREVENTING DEPRESSIVE RELAPSE; OVERVIEW OF MBCT; KEY PRINCIPLES; HOW MBCT IS SIMILAR AND DIFFERENT WITH CT AND MBSR; ASSESSMENT; CLINICAL CASE ILLUSTRATION; SPECIAL TOPICS; CONCLUSIONS AND FUTURE DIRECTIONS
REFERENCESINTERNET RESOURCES; Chapter 5: Relapse Prevention for Return of Pathological Worry in CBT-Treated GAD; INTRODUCTION TO GAD AND CLIENT POPULATION; ASSESSMENT OF GAD; GAD TREATMENT AND THE INCORPORATION OF RELAPSE PREVENTION; CASE EXAMPLE; WHAT IS PATHOLOGICAL WORRY?; WHY IS PATHOLOGICAL WORRY SO DIFFICULT TO STOP?; MINDFULNESS AND CBT FOR WORRY: HOPE FOR IMPROVED RESPONSE AND REDUCED RELAPSE; STRATEGIES FOR IMPLEMENTING MINDFULNESS INTO GAD CBT TREATMENT; POTENTIAL WAYS MINDFULNESS WORKS IN GAD TREATMENT; SPECIAL TOPICS; SUMMARY AND CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES
RESOURCE BIBLIOGRAPHY AND A LIST OF INTERNET LINKSChapter 6: Relapse Prevention for Schizophrenia; INTRODUCTION; OVERVIEW OF PSYCHOSOCIAL TREATMENT; CORE FEATURES OF CBT FOR SCHIZOPHRENIA; INTERVENTIONS TAILORED TO PREVENT RELAPSE; CO-OCCURRING ADDICTION AND MENTAL ILLNESS; IMPLEMENTATION OF RELAPSE PREVENTION INTERVENTIONS; CLINICAL CASE ILLUSTRATIONS; PHARMACOTHERAPY MEDICATION MANAGEMENT OF SCHIZOPHRENIA; CONCLUSIONS AND FUTURE DIRECTIONS; REFERENCES; Chapter 7: Seeking Safety: An Evidence-based Model for Substance Abuse and Trauma/PTSD; INTRODUCTION; OVERVIEW OF TREATMENT; KEY ELEMENTS
EMPIRICAL RESULTS
Record Nr. UNINA-9910458651403321
Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Therapist's guide to evidence-based relapse prevention [[electronic resource] /] / edited by Katie A. Witkiewitz, G. Alan Marlatt
Therapist's guide to evidence-based relapse prevention [[electronic resource] /] / edited by Katie A. Witkiewitz, G. Alan Marlatt
Pubbl/distr/stampa Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Descrizione fisica 1 online resource (394 p.)
Disciplina 616.891
616.8914
Altri autori (Persone) WitkiewitzKatie
MarlattG. Alan
Collana Practical resources for the mental health professional
Soggetto topico Mental illness - Relapse - Prevention
Substance abuse - Relapse - Prevention
Mental illness - Treatment
Substance abuse - Treatment
ISBN 1-280-96243-7
9786610962433
0-08-047104-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; Therapist's Guide to Evidence-Based Relapse Prevention; Copyright page; Table of contents; Contributors; Preface; SECTION I: Introduction andOverview; Chapter 1: Overview of Relapse Prevention; COGNITIVE-BEHAVIORAL MODEL OF RELAPSE; RELAPSE PREVENTION INTERVENTIONS; SUMMARY AND CONCLUSIONS; REFERENCES; Chapter 2: High-Risk Situations: Relapse as a Dynamic Process; COGNITIVE BEHAVIORAL MODEL OF RELAPSE, REVISED; TONIC PROCESSES; PHASIC PROCESSES; DYNAMICAL SYSTEMS PROCESSES; EMPIRICAL BASIS FOR DYNAMIC MODEL; CLINICAL CASE ILLUSTRATION; SUMMARY OF CLINICAL IMPLICATIONS
DYNAMIC RELAPSE MODEL AND NONSUBSTANCE USE BEHAVIORREFERENCES; SECTION II: Application of Relapse Prevention to Specific Problem Areas; Chapter 3: Relapse Prevention: Clinical Strategies for Substance Use Disorders; INTRODUCTION; OVERVIEW OF LAPSE, RELAPSE, AND RECOVERY; TREATMENT OUTCOMES AND RELAPSE RATES; EFFECTIVENESS AND EFFICACY OF RP; RELAPSE REPLICATION AND EXTENSION PROJECT; MODELS OF RELAPSE PREVENTION; RELAPSE-RELATED DOMAINS OF ASSESSMENT; RP INTERVENTIONS TO MINIMIZE LAPSE AND RELAPSE RISK; CLINICAL STRATEGIES TO REDUCE RELAPSE RISK
RP IN THE CONTEXT OF SUDs WITH COMORBID PSYCHIATRIC DISORDERSFUTURE RESEARCH DIRECTIONS; CLINICAL CASE ILLUSTRATIONS; CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; INTERNET RESOURCES; Chapter 4: Mindfulness-based Cognitive Therapy as a Relapse Prevention Approach to Depression; INTRODUCTION TO MINDFULNESS-BASED COGNITIVE THERAPY (MBCT); DEFINITION OF MINDFULNESS; EMPIRICAL SUPPORT FOR MBCT IN PREVENTING DEPRESSIVE RELAPSE; OVERVIEW OF MBCT; KEY PRINCIPLES; HOW MBCT IS SIMILAR AND DIFFERENT WITH CT AND MBSR; ASSESSMENT; CLINICAL CASE ILLUSTRATION; SPECIAL TOPICS; CONCLUSIONS AND FUTURE DIRECTIONS
REFERENCESINTERNET RESOURCES; Chapter 5: Relapse Prevention for Return of Pathological Worry in CBT-Treated GAD; INTRODUCTION TO GAD AND CLIENT POPULATION; ASSESSMENT OF GAD; GAD TREATMENT AND THE INCORPORATION OF RELAPSE PREVENTION; CASE EXAMPLE; WHAT IS PATHOLOGICAL WORRY?; WHY IS PATHOLOGICAL WORRY SO DIFFICULT TO STOP?; MINDFULNESS AND CBT FOR WORRY: HOPE FOR IMPROVED RESPONSE AND REDUCED RELAPSE; STRATEGIES FOR IMPLEMENTING MINDFULNESS INTO GAD CBT TREATMENT; POTENTIAL WAYS MINDFULNESS WORKS IN GAD TREATMENT; SPECIAL TOPICS; SUMMARY AND CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES
RESOURCE BIBLIOGRAPHY AND A LIST OF INTERNET LINKSChapter 6: Relapse Prevention for Schizophrenia; INTRODUCTION; OVERVIEW OF PSYCHOSOCIAL TREATMENT; CORE FEATURES OF CBT FOR SCHIZOPHRENIA; INTERVENTIONS TAILORED TO PREVENT RELAPSE; CO-OCCURRING ADDICTION AND MENTAL ILLNESS; IMPLEMENTATION OF RELAPSE PREVENTION INTERVENTIONS; CLINICAL CASE ILLUSTRATIONS; PHARMACOTHERAPY MEDICATION MANAGEMENT OF SCHIZOPHRENIA; CONCLUSIONS AND FUTURE DIRECTIONS; REFERENCES; Chapter 7: Seeking Safety: An Evidence-based Model for Substance Abuse and Trauma/PTSD; INTRODUCTION; OVERVIEW OF TREATMENT; KEY ELEMENTS
EMPIRICAL RESULTS
Record Nr. UNINA-9910784648303321
Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Therapist's guide to evidence-based relapse prevention / / edited by Katie A. Witkiewitz, G. Alan Marlatt
Therapist's guide to evidence-based relapse prevention / / edited by Katie A. Witkiewitz, G. Alan Marlatt
Edizione [1st ed.]
Pubbl/distr/stampa Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Descrizione fisica 1 online resource (394 p.)
Disciplina 616.891
616.8914
Altri autori (Persone) WitkiewitzKatie
MarlattG. Alan
Collana Practical resources for the mental health professional
Soggetto topico Mental illness - Relapse - Prevention
Substance abuse - Relapse - Prevention
Mental illness - Treatment
Substance abuse - Treatment
ISBN 1-280-96243-7
9786610962433
0-08-047104-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; Therapist's Guide to Evidence-Based Relapse Prevention; Copyright page; Table of contents; Contributors; Preface; SECTION I: Introduction andOverview; Chapter 1: Overview of Relapse Prevention; COGNITIVE-BEHAVIORAL MODEL OF RELAPSE; RELAPSE PREVENTION INTERVENTIONS; SUMMARY AND CONCLUSIONS; REFERENCES; Chapter 2: High-Risk Situations: Relapse as a Dynamic Process; COGNITIVE BEHAVIORAL MODEL OF RELAPSE, REVISED; TONIC PROCESSES; PHASIC PROCESSES; DYNAMICAL SYSTEMS PROCESSES; EMPIRICAL BASIS FOR DYNAMIC MODEL; CLINICAL CASE ILLUSTRATION; SUMMARY OF CLINICAL IMPLICATIONS
DYNAMIC RELAPSE MODEL AND NONSUBSTANCE USE BEHAVIORREFERENCES; SECTION II: Application of Relapse Prevention to Specific Problem Areas; Chapter 3: Relapse Prevention: Clinical Strategies for Substance Use Disorders; INTRODUCTION; OVERVIEW OF LAPSE, RELAPSE, AND RECOVERY; TREATMENT OUTCOMES AND RELAPSE RATES; EFFECTIVENESS AND EFFICACY OF RP; RELAPSE REPLICATION AND EXTENSION PROJECT; MODELS OF RELAPSE PREVENTION; RELAPSE-RELATED DOMAINS OF ASSESSMENT; RP INTERVENTIONS TO MINIMIZE LAPSE AND RELAPSE RISK; CLINICAL STRATEGIES TO REDUCE RELAPSE RISK
RP IN THE CONTEXT OF SUDs WITH COMORBID PSYCHIATRIC DISORDERSFUTURE RESEARCH DIRECTIONS; CLINICAL CASE ILLUSTRATIONS; CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; INTERNET RESOURCES; Chapter 4: Mindfulness-based Cognitive Therapy as a Relapse Prevention Approach to Depression; INTRODUCTION TO MINDFULNESS-BASED COGNITIVE THERAPY (MBCT); DEFINITION OF MINDFULNESS; EMPIRICAL SUPPORT FOR MBCT IN PREVENTING DEPRESSIVE RELAPSE; OVERVIEW OF MBCT; KEY PRINCIPLES; HOW MBCT IS SIMILAR AND DIFFERENT WITH CT AND MBSR; ASSESSMENT; CLINICAL CASE ILLUSTRATION; SPECIAL TOPICS; CONCLUSIONS AND FUTURE DIRECTIONS
REFERENCESINTERNET RESOURCES; Chapter 5: Relapse Prevention for Return of Pathological Worry in CBT-Treated GAD; INTRODUCTION TO GAD AND CLIENT POPULATION; ASSESSMENT OF GAD; GAD TREATMENT AND THE INCORPORATION OF RELAPSE PREVENTION; CASE EXAMPLE; WHAT IS PATHOLOGICAL WORRY?; WHY IS PATHOLOGICAL WORRY SO DIFFICULT TO STOP?; MINDFULNESS AND CBT FOR WORRY: HOPE FOR IMPROVED RESPONSE AND REDUCED RELAPSE; STRATEGIES FOR IMPLEMENTING MINDFULNESS INTO GAD CBT TREATMENT; POTENTIAL WAYS MINDFULNESS WORKS IN GAD TREATMENT; SPECIAL TOPICS; SUMMARY AND CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES
RESOURCE BIBLIOGRAPHY AND A LIST OF INTERNET LINKSChapter 6: Relapse Prevention for Schizophrenia; INTRODUCTION; OVERVIEW OF PSYCHOSOCIAL TREATMENT; CORE FEATURES OF CBT FOR SCHIZOPHRENIA; INTERVENTIONS TAILORED TO PREVENT RELAPSE; CO-OCCURRING ADDICTION AND MENTAL ILLNESS; IMPLEMENTATION OF RELAPSE PREVENTION INTERVENTIONS; CLINICAL CASE ILLUSTRATIONS; PHARMACOTHERAPY MEDICATION MANAGEMENT OF SCHIZOPHRENIA; CONCLUSIONS AND FUTURE DIRECTIONS; REFERENCES; Chapter 7: Seeking Safety: An Evidence-based Model for Substance Abuse and Trauma/PTSD; INTRODUCTION; OVERVIEW OF TREATMENT; KEY ELEMENTS
EMPIRICAL RESULTS
Altri titoli varianti Evidence-based relapse prevention
Record Nr. UNINA-9910813758403321
Amsterdam ; ; Boston, : Elsevier Academic Press, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui